Remove Embolism Remove Peripheral Arterial Disease Remove Stroke
article thumbnail

Sensome Announces Initiation of Clinical Trial Assessing Its Tissue Microsensor Technology in Peripheral Artery Disease

DAIC

Getty Images milla1cf Mon, 02/12/2024 - 15:22 February 12, 2024 — Sensome , a company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today enrollment of the first patients into a feasibility clinical study using the Clotild Smart Guidewire in peripheral artery disease (PAD).

article thumbnail

HonorHealth Research Institute First in Southwest to Implant New Stroke Prevention Stent

DAIC

The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease, a condition in which fatty-waxy deposits known as plaque builds up and blocks the normal flow of blood in the large arteries on either side of the neck.

Stents 111
article thumbnail

Education and cardiovascular diseases: a Mendelian randomization study

Frontiers in Cardiovascular Medicine

Specifically, this genetic factor was found to lower the risk of type 2 diabetes by 46.5%, coronary heart disease by 37.5%, ischemic stroke by 35.4%, cardiac-related mortality by 28.6%, heart failure by 28.2%, transient ischemic attack by 24%, atrial fibrillation by 15.2%, peripheral artery disease by 0.3%, and hypertension by 0.3%.

article thumbnail

Abstract 016: Endovascular Coiling of a Left L3 Radicular Artery Mycotic Aneurysm

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionMycotic aneurysms of paraspinal arteries are a rare finding. Furthermore, knowledge regarding the management of paraspinal mycotic aneurysms and the efficacy of endovascular repair of these lesions is scarce.⁴MethodsWe

article thumbnail

ACC/AHA Release Updated 2023 Guidelines for Atrial Fibrillation

Cardiometabolic Health Congress

AF is associated with an increased risk of death as well as multiple adverse outcomes, including stroke, cognitive impairment or dementia, myocardial infarction, sudden cardiac death, heart failure (HF), chronic kidney disease (CKD), and peripheral artery disease (PAD).

article thumbnail

Abstract 136: Infarct Topography, Effect of Anticoagulation, and Recurrence after Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA Trial

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page A136-A136, February 1, 2025. Introduction:The ARCADIA trial found no benefit of anticoagulation for secondary stroke prevention in patients with cryptogenic stroke and evidence of atrial cardiopathy. The trial screened all patients with cryptogenic stroke, regardless of infarct topography.

Stroke 40
article thumbnail

CircRNA-mediated regulation of cardiovascular disease

Frontiers in Cardiovascular Medicine

Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g., stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism.